🇺🇸 FDA
Pipeline program

Vehicle to Mecloderm Ointment, LOTRICOMB® Salbe, 0,64 mg/g + 10 mg/g, Salbe, Mecloderm Ointment

21-01/ClotriBet-S

Phase 3 small_molecule active

Quick answer

Vehicle to Mecloderm Ointment, LOTRICOMB® Salbe, 0,64 mg/g + 10 mg/g, Salbe, Mecloderm Ointment for moderate to severely inflamed candidiasis of the skin is a Phase 3 program (small_molecule) at Pharm Research Associates (UK) Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Pharm Research Associates (UK) Limited
Indication
moderate to severely inflamed candidiasis of the skin
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials